Scarica l'app Stockscreener
5.95
6.06%
0.34
Dopo l'orario di chiusura:
5.90
-0.05
-0.84%
Precedente Chiudi:
$5.61
Aprire:
$5.59
Volume 24 ore:
6.82M
Relative Volume:
1.67
Capitalizzazione di mercato:
$924.91M
Reddito:
$2.80M
Utile/perdita netta:
$-115.18M
Rapporto P/E:
-7.0223
EPS:
-0.8473
Flusso di cassa netto:
$-94.03M
1 W Prestazione:
+26.33%
1M Prestazione:
+101.01%
6M Prestazione:
+65.74%
1 anno Prestazione:
+124.53%
Intervallo 1D:
$5.59
$6.235
Intervallo di 1 settimana:
$4.675
$6.235
Portata 52W:
$2.24
$6.235
Absci Corp Stock (ABSI) Company Profile
Nome
Absci Corp
Settore
Industria
Telefono
(360) 949-1041
Indirizzo
18105 SE MILL PLAIN BLVD, VANCOUVER
Compare ABSI vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
5.95 | 872.06M | 2.80M | -115.18M | -94.03M | -0.8473 |
VRTX
Vertex Pharmaceuticals Inc
|
427.65 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-08 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-10-02 | Iniziato | JP Morgan | Overweight |
| 2025-07-03 | Ripresa | Morgan Stanley | Overweight |
| 2025-01-22 | Iniziato | Needham | Buy |
| 2024-10-02 | Iniziato | Guggenheim | Buy |
| 2024-07-03 | Iniziato | Morgan Stanley | Overweight |
| 2024-03-14 | Iniziato | Scotiabank | Sector Outperform |
| 2023-12-05 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2023-05-04 | Iniziato | H.C. Wainwright | Buy |
| 2022-08-12 | Downgrade | JP Morgan | Overweight → Underweight |
| 2022-07-18 | Iniziato | Truist | Buy |
| 2022-03-02 | Ripresa | Cowen | Market Perform |
| 2022-02-01 | Iniziato | Berenberg | Buy |
| 2021-11-10 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-10-15 | Ripresa | Cowen | Market Perform |
| 2021-08-16 | Iniziato | BofA Securities | Neutral |
| 2021-08-16 | Iniziato | Cowen | Market Perform |
| 2021-08-16 | Iniziato | Credit Suisse | Outperform |
| 2021-08-16 | Iniziato | Stifel | Hold |
Mostra tutto
Absci Corp Borsa (ABSI) Ultime notizie
New Absci hire gets option to buy 276,200 shares at $4.92 - Stock Titan
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Absci (NASDAQ:ABSI) Hits New 1-Year HighStill a Buy? - MarketBeat
Earnings Preview: Absci Corp to Report Financial Results Post-market on May 07 - 富途牛牛
waiting to hit above $7 - Moomoo
Here is Why Absci Corp. (ABSI) is One of the Best Biotech Penny Stocks to Buy in 2026 - Yahoo Finance
5 Best Biotech Penny Stocks to Buy in 2026 - Insider Monkey
Absci, DigitalOcean and other big stocks moving lower in Wednesday's pre-market session - MSN
Absci (ABSI) Expected to Announce Earnings on Thursday - MarketBeat
ABSIAbsci Corp Stock Price and Quote - Finviz
H.C. Wainwright Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $8 - 富途牛牛
H.C. Wainwright reiterates Absci stock rating on hair loss data By Investing.com - Investing.com Australia
H.C. Wainwright reiterates Absci stock rating on hair loss data - Investing.com
Absci Corporation (ABSI) reports Q4 loss, misses revenue estimates - MSN
Absci Corporation (ABSI) Reports Q3 Loss, Lags Revenue Estimates - MSN
Absci (NASDAQ:ABSI) Sees Large Volume IncreaseShould You Buy? - MarketBeat
Absci stock surges 22% on hair-loss drug market optimism By Investing.com - Investing.com India
Absci stock surges 22% on hair-loss drug market optimism - Investing.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Absci files $400M mixed securities shelf - MSN
Absci climbs on clinical trial acceleration - MSN
Absci Corp Establishes Advisory Board to Advance Endometriosis Drug - HarianBasis.co
Absci Corp. (ABSI) Offering Impressive Upside to Potential Investors - Insider Monkey
Absci announces proposed public offering of common stock - MSN
10 Most Shorted Penny Stocks to Buy - Insider Monkey
JonesTrading Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $9 - 富途牛牛
Needham Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $7 - 富途牛牛
Absci (NASDAQ:ABSI) Shares Up 7.7%Should You Buy? - MarketBeat
Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026 - The Manila Times
Absci sets May 7 webcast for Q1 results and business update - Stock Titan
Absci (NASDAQ: ABSI) sets 2026 virtual vote, highlights ABS-201 and Origin-1 AI - Stock Titan
ABSI Stock Climbs As AI Drug Program Gains Traction - StocksToTrade
We Think Absci (NASDAQ:ABSI) Needs To Drive Business Growth Carefully - 富途牛牛
Absci (NASDAQ:ABSI) Stock Price Up 11%Still a Buy? - MarketBeat
Massachusetts Financial Services Co. MA Cuts Position in Absci Corporation $ABSI - MarketBeat
Absci Highlights AI Antibody Platform, Teases ABS-201 Hair-Loss Data and 2026 Milestones at Needham Conference - MarketBeat
Truist Financial Maintains Absci Corp(ABSI.US) With Buy Rating - 富途牛牛
Redmile funds cut Absci (ABSI) holdings below 5% after share sale - Stock Titan
Absci Corp | SCHEDULE 13D/A: Others - Moomoo
JP Morgan Initiates Overweight Rating on Absci (ABSI) | ABSI Sto - GuruFocus
Portland InnoAbsci's move into generative AI | Why former Hydro Flask CEO joined Puffin - The Business Journals
Absci Corp Azioni (ABSI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.77%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):